lycorine has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, G; Koo, S; Lu, J; Luo, Y; Qiu, Y; Shao, Y; Wang, K; Wang, T; Yang, S; Yin, S; Yu, H; Zhou, S | 1 |
| Hu, C; Huang, J; Li, G; Liu, W; Liu, Y; Lu, Y; Tang, Q; Wang, Q; Zhang, Q; Zhang, R | 1 |
2 other study(ies) available for lycorine and Liver Neoplasms
| Article | Year |
|---|---|
Cyclin-dependent kinase 1 as a potential target for lycorine against hepatocellular carcinoma.
Topics: Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; CDC2 Protein Kinase; Cell Line, Tumor; Cellular Senescence; Cyclin B1; Cyclin B2; Drug Delivery Systems; Gene Expression Regulation, Enzymologic; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Molecular Structure; Phenanthridines; Xenograft Model Antitumor Assays | 2021 |
Lycorine inhibits cell proliferation and migration by inhibiting ROCK1/cofilin‑induced actin dynamics in HepG2 hepatoblastoma cells.
Topics: Actins; Amaryllidaceae Alkaloids; Apoptosis; Biomarkers, Tumor; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Cofilin 1; Gene Expression Regulation, Neoplastic; Hepatoblastoma; Humans; Liver Neoplasms; Phenanthridines; rho-Associated Kinases; Tumor Cells, Cultured | 2018 |